ID   SIA7C_RAT               Reviewed;         305 AA.
AC   Q64686;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JAN-2024, entry version 126.
DE   RecName: Full=Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3;
DE            EC=2.4.3.7 {ECO:0000269|PubMed:8631773};
DE   AltName: Full=GalNAc alpha-2,6-sialyltransferase III;
DE   AltName: Full=ST6GalNAc III {ECO:0000303|PubMed:8631773};
DE            Short=ST6GalNAcIII;
DE   AltName: Full=STY;
DE   AltName: Full=Sialyltransferase 7C;
DE            Short=SIAT7-C;
GN   Name=St6galnac3; Synonyms=Siat7c;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8631773; DOI=10.1074/jbc.271.13.7450;
RA   Sjoberg E.R., Kitagawa H., Glushka J., van Halbeek H., Paulson J.C.;
RT   "Molecular cloning of a developmentally regulated N-acetylgalactosamine
RT   alpha2,6-sialyltransferase specific for sialylated glycoconjugates.";
RL   J. Biol. Chem. 271:7450-7459(1996).
CC   -!- FUNCTION: Transfers the sialyl group (N-acetyl-alpha-neuraminyl or
CC       NeuAc) from CMP-NeuAc to the GalNAc residue on the NeuAc-alpha-2,3-Gal-
CC       beta-1,3-GalNAc sequence of glycoproteins and glycolipids forming an
CC       alpha-2,6-linkage. Produces branched type disialyl structures by
CC       transfer of a sialyl group onto a GalNAc residue inside the backbone
CC       core chains. ST6GalNAcIII prefers glycolipids to glycoproteins,
CC       predominantly catalyzing the biosynthesis of ganglioside GD1alpha from
CC       GM1b (PubMed:8631773). GD1alpha is a critical molecule in the
CC       communication and interaction between neuronal cells and their
CC       supportive cells, particularly in brain tissues, and functions as an
CC       adhesion molecule in the process of metastasis (By similarity).
CC       Sialylation of glycoproteins or glycosphingolipids is very important in
CC       tumor development, neuronal development, nerve repair, immunological
CC       processes and regulation of hormone sensitivity (By similarity).
CC       {ECO:0000250|UniProtKB:Q8NDV1, ECO:0000250|UniProtKB:Q9QYJ1,
CC       ECO:0000269|PubMed:8631773}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-D-GlcNAc derivative +
CC         CMP-N-acetyl-beta-neuraminate = an alpha-Neu5Ac-(2->3)-beta-D-Gal-
CC         (1->3)-[alpha-Neu5Ac-(2->6)]-D-GlcNAc-R + CMP + H(+);
CC         Xref=Rhea:RHEA:53896, ChEBI:CHEBI:15378, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:146021, ChEBI:CHEBI:149714;
CC         EC=2.4.3.7; Evidence={ECO:0000269|PubMed:8631773};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53897;
CC         Evidence={ECO:0000305|PubMed:8631773};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ganglioside GM1b + CMP-N-acetyl-beta-neuraminate = a
CC         ganglioside GD1alpha + CMP + H(+); Xref=Rhea:RHEA:48316,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57812, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:90151, ChEBI:CHEBI:90246;
CC         Evidence={ECO:0000269|PubMed:8631773};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48317;
CC         Evidence={ECO:0000305|PubMed:8631773};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ganglioside GM1b (d18:1(4E)) + CMP-N-acetyl-beta-neuraminate
CC         = a ganglioside GD1alpha (d18:1(4E)) + CMP + H(+);
CC         Xref=Rhea:RHEA:41968, ChEBI:CHEBI:15378, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:78568, ChEBI:CHEBI:78569;
CC         Evidence={ECO:0000250|UniProtKB:Q9WUV2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41969;
CC         Evidence={ECO:0000250|UniProtKB:Q9WUV2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a globoside MSGG + CMP-N-acetyl-beta-neuraminate = a globoside
CC         DSGG + CMP + H(+); Xref=Rhea:RHEA:56088, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57812, ChEBI:CHEBI:60377, ChEBI:CHEBI:140623,
CC         ChEBI:CHEBI:140624; Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56089;
CC         Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc]-L-
CC         Ser-[protein] + CMP-N-acetyl-beta-neuraminate = 3-O-{alpha-Neu5Ac-
CC         (2->3)-beta-D-Gal-(1->3)-[alpha-Neu5Ac-(2->6)]-alpha-D-GalNAc}-L-Ser-
CC         [protein] + CMP + H(+); Xref=Rhea:RHEA:65280, Rhea:RHEA-COMP:16760,
CC         Rhea:RHEA-COMP:16761, ChEBI:CHEBI:15378, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:156395, ChEBI:CHEBI:156397;
CC         Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65281;
CC         Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc]-L-
CC         Thr-[protein] + CMP-N-acetyl-beta-neuraminate = 3-O-{alpha-Neu5Ac-
CC         (2->3)-beta-D-Gal-(1->3)-[alpha-Neu5Ac-(2->6)]-alpha-D-GalNAc}-L-Thr-
CC         [protein] + CMP + H(+); Xref=Rhea:RHEA:65284, Rhea:RHEA-COMP:16762,
CC         Rhea:RHEA-COMP:16763, ChEBI:CHEBI:15378, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:156396, ChEBI:CHEBI:156398;
CC         Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65285;
CC         Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000305|PubMed:8631773}.
CC   -!- PATHWAY: Glycolipid biosynthesis. {ECO:0000305|PubMed:8631773}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-
CC       pass type II membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: In adults it is highly expressed in spleen,
CC       followed by kidney and lesser in lung. Not found in liver and skeletal
CC       muscle. In newborns it is abundantly expressed in brain and kidney.
CC       {ECO:0000269|PubMed:8631773}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 29 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29554; AAC42086.1; -; mRNA.
DR   RefSeq; NP_061996.1; NM_019123.1.
DR   AlphaFoldDB; Q64686; -.
DR   STRING; 10116.ENSRNOP00000073209; -.
DR   BindingDB; Q64686; -.
DR   ChEMBL; CHEMBL2198; -.
DR   SwissLipids; SLP:000001429; -.
DR   CAZy; GT29; Glycosyltransferase Family 29.
DR   GlyCosmos; Q64686; 2 sites, No reported glycans.
DR   GlyGen; Q64686; 2 sites.
DR   PhosphoSitePlus; Q64686; -.
DR   PaxDb; 10116-ENSRNOP00000068331; -.
DR   Ensembl; ENSRNOT00055048262; ENSRNOP00055039682; ENSRNOG00055027884.
DR   Ensembl; ENSRNOT00060002333; ENSRNOP00060001510; ENSRNOG00060001550.
DR   Ensembl; ENSRNOT00065020550; ENSRNOP00065015803; ENSRNOG00065012623.
DR   GeneID; 29758; -.
DR   KEGG; rno:29758; -.
DR   AGR; RGD:3677; -.
DR   CTD; 256435; -.
DR   RGD; 3677; St6galnac3.
DR   eggNOG; KOG2692; Eukaryota.
DR   InParanoid; Q64686; -.
DR   OrthoDB; 5348004at2759; -.
DR   PhylomeDB; Q64686; -.
DR   Reactome; R-RNO-4085001; Sialic acid metabolism.
DR   Reactome; R-RNO-977068; Termination of O-glycan biosynthesis.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q64686; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001665; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; IBA:GO_Central.
DR   GO; GO:0047290; F:alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity; IEA:RHEA.
DR   GO; GO:0008373; F:sialyltransferase activity; IDA:RGD.
DR   GO; GO:0001574; P:ganglioside biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009100; P:glycoprotein metabolic process; ISO:RGD.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; ISO:RGD.
DR   GO; GO:0006677; P:glycosylceramide metabolic process; ISO:RGD.
DR   GO; GO:0009311; P:oligosaccharide metabolic process; IBA:GO_Central.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.90.1480.20; Glycosyl transferase family 29; 1.
DR   InterPro; IPR001675; Glyco_trans_29.
DR   InterPro; IPR038578; GT29-like_sf.
DR   PANTHER; PTHR45906; -; 1.
DR   PANTHER; PTHR45906:SF2; ALPHA-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3; 1.
DR   Pfam; PF00777; Glyco_transf_29; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Lipid metabolism; Membrane; Reference proteome; Sialic acid; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..305
FT                   /note="Alpha-N-acetylgalactosaminide alpha-2,6-
FT                   sialyltransferase 3"
FT                   /id="PRO_0000149277"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..29
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..305
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        80..229
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   305 AA;  35150 MW;  9077F6547D359AE9 CRC64;
     MACILKRKPA LAVSFIALCI LLLAMRLAND VTFPLLLNCF GQPKTKWIPL SYTLRQPLQT
     HYGYINVRTQ EPLQLNCNHC AVVSNSGQMV GQKVGEEIDR ASCIWRMNNA PTKGFEEDVG
     YMTMVRVVSH TSVPLLLKNP DYFFKEASTT IYVIWGPFRN MRKDGNGIVY NMLKKTVDAY
     PDAQIYVTTE QRMTYCDGVF KDETGKDRVQ SGSYLSTGWF TFILAMDACY SIHVYGMINE
     TYCTTEGYRK VPYHYYEQGK DECNEYLLHE HAPYGGHRFI TEKKVFAKWA KKHRIVFTHP
     NWTVS
//
